OBJECTIVE: To investigate the anti-apoptotic role of tumor necrosis factor-a (TNF-a) and its signaling pathways in cultured human fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis. METHODS: FLS were cultured in Dulbecco's modified Eagle's medium. Apoptotic cells were identified by TUNEL assay and Hoechst staining. Cell viability was determined by the MTT method. Expression of phospho-Akt and phospho-BAD was measured by Western blotting. RESULTS: A 24-h TNF-a treatment prevented FLS apoptosis induced by nitric oxide (NO) donor sodium nitroprusside dihydrate (SNP), achieving 70% protection. At 1-10 ng x ml-1 concentrations, TNF-a induced phosphorylation of Akt and BAD in a time and concentration-dependent manner. This effect was blocked by treatment with both LY294002 and nuclear factor-kB inhibitor pyrrolidine-dithiocarbamate. CONCLUSION: TNF-a has an anti-apoptotic effect in human FLS. Activation of Akt and BAD may have an important role in this process.
OBJECTIVE: To investigate the anti-apoptotic role of tumor necrosis factor-a (TNF-a) and its signaling pathways in cultured human fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis. METHODS: FLS were cultured in Dulbecco's modified Eagle's medium. Apoptotic cells were identified by TUNEL assay and Hoechst staining. Cell viability was determined by the MTT method. Expression of phospho-Akt and phospho-BAD was measured by Western blotting. RESULTS: A 24-h TNF-a treatment prevented FLS apoptosis induced by nitric oxide (NO) donorsodium nitroprusside dihydrate (SNP), achieving 70% protection. At 1-10 ng x ml-1 concentrations, TNF-a induced phosphorylation of Akt and BAD in a time and concentration-dependent manner. This effect was blocked by treatment with both LY294002 and nuclear factor-kB inhibitor pyrrolidine-dithiocarbamate. CONCLUSION:TNF-a has an anti-apoptotic effect in human FLS. Activation of Akt and BAD may have an important role in this process.
Authors: Ana Carolina Matias Dinelly Pinto; Rossana de Aguiar Cordeiro; José Julio Costa Sidrim; Ana Karine Rocha de Melo Leite; Ana Caroline Rocha de Melo Leite; Virgínia Cláudia Carneiro Girão; Raimunda Sâmia Nogueira Brilhante; Marcos Fábio Gadelha Rocha; Fernando de Queiroz Cunha; Francisco Airton Castro Rocha Journal: Mycopathologia Date: 2013-02-05 Impact factor: 2.574
Authors: Myew-Ling Toh; Gaelle Gonzales; Marije I Koenders; Anne Tournadre; David Boyle; Erik Lubberts; Yuan Zhou; Gary S Firestein; Wim B van den Berg; Pierre Miossec Journal: PLoS One Date: 2010-10-15 Impact factor: 3.240
Authors: Calogera M Simonaro; Marina D'Angelo; Xingxuan He; Efrat Eliyahu; Nataly Shtraizent; Mark E Haskins; Edward H Schuchman Journal: Am J Pathol Date: 2007-12-13 Impact factor: 4.307
Authors: Joseph M McCoy; Dana E Walkenhorst; Keegan S McCauley; Hiba Elaasar; Jordan R Everett; Kimberlee S Mix Journal: J Inflamm (Lond) Date: 2015-02-18 Impact factor: 4.981
Authors: Eun Ha Kang; Dong Jo Kim; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song Journal: Arthritis Res Ther Date: 2009-08-27 Impact factor: 5.156